672
Participants
Start Date
April 30, 2005
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Trabectedin
Type=exact number, unit=mg/m2, number=1.1, form=solution, route=IV. Trabectedin will be administered over 3 hours every 3 weeks.
DOXIL
Type=exact number, unit=mg/m2, number=30, 50, form=solution, route=IV. DOXIL will be administered over 90 minutes every 4 weeks when administered alone (monotherapy) and every 3 weeks when administered with trabectedin.
Dexamethasone
Type=exact number, unit=mg, number=20, form=solution, route=IV. Dexamethasone or its equivalent will be administered over 30 minutes prior to the DOXIL infusion.
Mobile
Tucson
Los Angeles
Newport Beach
Orange
Englewood
Stamford
Tampa
Coeur d'Alene
Louisville
New Orleans
Boston
Minneapolis
St Louis
Morristown
New York
Charlotte
Greenville
Winston-Salem
Cleveland
Toledo
Portland
Pittsburgh
Greenville
Chattanooga
Nashville
Dallas
Galveston
Buenos Aires
Mendoza
Sante Fe
Adelaide
Bentleigh
Douglas
St Leonards
Toorak Gardens
Edegem
Hasselt
Leuven
Wilrijk
Barretos
Belo Horizonte
Cerqueira César
Londrina
Santo André
São Paulo
Calgary
Edmonton
Ottawa
Montreal
Québec
Reneca
Santiago
Beijing
Guangzhou
Hangzhou
Jinan
Shanghai
Chartres
Paris
Pierre-Bénite
Düsseldorf
Heidelberg
Jena
Karlsruhe
Mainz
Villingen-Schwenningen
Wilhelmshaven
Chai Wan
Hong Kong
Shatin
Amsterdam
Enschede
Groningen
Maastricht
Gdansku
Gliwice
Krakow
Olsztyn
Poznan
Warszawa Poland
Wroclaw
Chelyabinsk
Moscow
Obninsk, Kaluga Region
Orenburg
Saint Petersburg
Samara
Singapore
Seoul
Barcelona
Girona
Guadalajara
L'Hospitalet de Llobregat
Madrid
Marañón
Valencia
Zaragoza
Gothenburg
Umeå
Uppsala
Kaohsiung County
Taipei
Taoyuan District
Birmingham
Edinburgh
Leicester
London
Nottingham
Poole
Sheffield
Collaborators (1)
PharmaMar
INDUSTRY
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY